Next Article in Journal / Special Issue
Efficient Expression of Antibody Fragments with the Brevibacillus Expression System
Previous Article in Journal
Kinetic Characterization of a Panel of High-Affinity Monoclonal Antibodies Targeting Ricin and Recombinant Re-Formatting for Biosensor Applications
Previous Article in Special Issue
The Biotechnological Applications of Recombinant Single-Domain Antibodies are Optimized by the C-Terminal Fusion to the EPEA Sequence (C Tag)
Antibodies 2014, 3(2), 232-241; doi:10.3390/antib3020232
Review

Refolding Technologies for Antibody Fragments

1,*  and 2
Received: 20 January 2014 / Revised: 26 April 2014 / Accepted: 13 May 2014 / Published: 23 May 2014
(This article belongs to the Special Issue Antibody Constructs)
View Full-Text   |   Download PDF [343 KB, 26 May 2014; original version 23 May 2014]   |   Browse Figures

Abstract

Refolding is one of the production technologies for pharmaceutical grade antibody fragments. Detergents and denaturants are primarily used to solubilize the insoluble proteins. The solubilized and denatured proteins are refolded by reducing the concentration of the denaturants or detergents. Several refolding technologies have been used for antibody fragments, comprising dilution, dialysis, solid phase solvent exchange and size exclusion chromatography, as reviewed here. Aggregation suppressor or folding-assisting agents, including arginine hydrochloride, ionic liquids and detergents or denaturants at low concentrations, are included in the refolding solvent to enhance refolding yield.
Keywords: refolding; dialysis; dilution; C12-L-Glu; antibody; fragments refolding; dialysis; dilution; C12-L-Glu; antibody; fragments
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Share & Cite This Article

Further Mendeley | CiteULike
Export to BibTeX |
EndNote
MDPI and ACS Style

Arakawa, T.; Ejima, D. Refolding Technologies for Antibody Fragments. Antibodies 2014, 3, 232-241.

View more citation formats

Article Metrics

Comments

Citing Articles

[Return to top]
Antibodies EISSN 2073-4468 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert